Evidence suggests that even when advanced prostate cancer becomes resistant to androgen deprivation therapy (Lupron or Zoladex), it is useful to continue on androgen deprivation because excess testosterone still allows for cancer cells to progress faster and spread throughout the body.
van der Sluis TM, Bijnsdorp IV, Jacobs JJ, Meuleman EJ, Rozendaal L, Geldof AA, van Moorselaar RJ, Vis AN. Serum testosterone plays an important role in the metastatic ability of castration resistant prostate cancer. World Journal of Urology. 2012 Oct 19.
Good post. I’ve been searching on this. Looking forward to your next post!!!
Continue the good work and people will continue to come to your blog! I have been updating my blogs, as well.
Great writers aren’t easy to come by – I think you have done a amazing job here. Nice Job.
You should make an eBook with this post.
All I can say is you hit that right on the target – I agree completely!